U.S. Markets closed

Reading Filings to Predict Future Events

HENDERSON, NV / ACCESSWIRE / November 1, 2018 /One of the best ways to predict major announcements is by pouring through filings. Sometimes you can find interesting bits that may signal larger announcements. That's why we're so interested in CleanSpark, Inc. (CLSK). Not only have they engineered world-class power solutions for major cannabis players. CLSK also released a filing that showed they just signed an $18 million-dollar deal with Macerich and NYSE company that is valued at billions of dollars. Not every investor digs into filings, and with a major deal like this happening under the surface, it's a matter of time before we start seeing some major releases. They've also recently upgraded audit firms, and filed a registration statement. This could be a the prelude to an uplisting.

Make sure to put some time into researching CLSK today.

Stocks to put on your radar include: CleanSpark, Inc. (CLSK),The Green Dutchman Holdings, Ltd. (OTC PINK: TGDOF), Freedom Leaf, Inc. (OTC PINK: FRLF), ICC International Cannabis Corp. (KNHBF), and Liberty Health Sciences, Inc. (LHSIF).

CleanSpark, Inc. (CLSK)

Market Cap: $87.66M Share Price: $2.49

CleanSpark, Inc. (CLSK), is a unique company that offers microgrid solutions for a variety of clients. Matthew Schultz, CEO of CleanSpark, Inc talked with Stock Day's Marcus Heatherly about what they have to offer in energy and software solutions. To listen to the full interview with Matthew Schultz, click the link to the podcast here: https://upticknewswire.com/featured-interview-ceo-s-matthew-schultz-of-cleanspark-inc-otcqb-clsk/

The Green Dutchman Holdings, Ltd. (TGDOF)

Market Cap: $628.53M Share Price: $2.38

The Green Organic Dutchman Holdings Ltd. announced two strategic appointments within its leadership team, with Emily Demeo joining as Marketing Brand Director and Terry Reid joining as Director, Legal and Compliance.

Freedom Leaf, Inc. (FRLF)

Market Cap: $59.68M Share Price: $0.27

Freedom Leaf, Inc. has surprised analysts and investors by exceeding its revenue guidance for its last quarter of its June 30 2018 fiscal year of $400K issued in a press release on July 3rd by 47% delivering revenue of $590K. Additionally its latest acquisition, Tierra Sciences Global, has generated $167K in the first 30 days of their prelaunch in affiliate marketing campaign.The company projects that the first quarter of our current fiscal year will be above approximately $600,000.

Zynerba Pharmaceuticals Inc. (ZYNE)

Market Cap: $117.20M, current share price: $6.65

Zynerba Pharmaceuticals, Inc. focuses on developing and commercializing pharmaceutically-produced transdermal cannabinoid treatments for rare or near-rare neuropsychiatric disorders. Its product candidates include ZYN002, which completed Phase II clinical trial for pediatric and adolescent patients with fragile X syndrome, pediatric and adolescent patients with developmental and epileptic encephalopathies, and adult patients with refractory epileptic focal seizures; and ZYN001 that is in Phase I clinical trial to treat Tourette syndrome.

Liberty Health Sciences, Inc. (LHSIF)

Market Cap: $339.41M Share Price: $0.97

Liberty Health Sciences Inc., a provider of high quality cannabis, announced the planned opening this week of three of its newest Cannabis Education Center (CEC) dispensaries in Winter Haven, FL; Palm Harbor, FL, and Merritt Island, FL featuring free 24-hour delivery service throughout Florida. Opening for the Palm Harbor and Merritt Island locations are subject to DOH approval.

Important Disclaimer, Please Read:

The securities, investments, and industries referenced and impacted in the attached content, are risky investments, that can result in significant or entire loss. This article is not advice in making any speculative investment decision.

The attached content may include predictions, estimates or other information that might be considered forward-looking. While such forward-looking statements represent best judgment on what the future holds, at the time of first publishing, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on any forward-looking statements, that may be found in the attached content, as they only reflect as of the date of first publishing. Please keep in mind that authors, producers, disseminators are not obligated to revise or publicly release the results of any revision to any forward-looking statement, that may be found in the attached content, in light of new information or future events.

Regal Consulting LLC is hired by certain companies to increase awareness and disseminate material public information regarding the paying company. CLSK has paid, and continues to pay Regal to disseminate truthful and potentially material information regarding CLSK.

Regal Consulting LLC is not registered with FINRA or any other financial or securities regulatory authority, and does not provide investment advice. The attached content is not investment advice. Regal Consulting LLC is not a broker dealer.

Before making investment decisions, everyone, including viewers of this content, should seek advice and perform deep and thorough research.

Regal Consulting, LLC. may buy or sell additional shares of any company named, referenced, or impacted by information in the attached content, on the open market at any time, including before, during or after the publishing of the content. The amount of stock Regal may own in CLSK can be found updated here: http://www.regalconsultingllc.com/disclaimer/.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and eleven thousand dollars total by Regal Consulting. LLC, for news commentary articles for CLSK. CLSK and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. We may buy or sell additional shares of CLSK in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

For Full Legal Disclaimer Click Here.

Regal Consulting, LLC,For Full Legal Disclaimer Click Here.

Contact Information:
Company Name: Microcap Speculators
Contact Person:
Media Manager
Email:
info@microcapspecualtors.com
Phone:
1-702-720-6310
Country:
United States
Website:
http://microcapspeculators.com/

SOURCE: ACR Communication, LLC